Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study.

Bousquet J, Devillier P, Anto JM, Bewick M, Haahtela T, Arnavielhe S, Bedbrook A, Murray R, van Eerd M, Fonseca JA, Morais Almeida M, Todo Bom A, Menditto E, Passalacqua G, Stellato C, Triggiani M, Ventura MT, Vezzani G, Annesi-Maesano I, Bourret R, Bosse I, Caimmi D, Cartier C, Demoly P, Just J, Portejoie F, Siroux V, Viart F, Bergmann KC, Keil T, Klimek L, Mösges R, Pfaar O, Shamai S, Zuberbier T, Mullol J, Valero A, Spranger O, Tomazic PV, Kowalski ML, Kuna P, Kupczyk M, Raciborski F, Samolinski B, Toppila-Salmi SK, Valovirta E, Cruz AA, Sarquis-Serpa F, da Silva J, Stelmach R, Larenas-Linnemann D, Rodriguez Gonzalez M, Burguete Cabañas MT, Kvedariene V, Valiulis A, Chavannes NH, Fokkens WJ, Ryan D, Sheikh A, Bachert C, Hellings PW, VandenPlas O, Ballardini N, Kull I, Melén E, Westman M, Wickman M, Bindslev-Jensen C, Eller E, Bosnic-Anticevich S, O'Hehir RE, Agache I, Bieber T, Casale T, Gemicioğlu B, Ivancevich JC, De Vries G, Sorensen M, Yorgancioglu A, Laune D; MACVIA working group.

Allergy. 2018 Aug;73(8):1622-1631. doi: 10.1111/all.13448. Epub 2018 Apr 24. Review.

PMID:
29569295
2.

Benralizumab: an anti-IL-5 receptor α monoclonal antibody in the treatment of asthma.

Kupczyk M, Kuna P.

Immunotherapy. 2018 Apr;10(5):349-359. doi: 10.2217/imt-2017-0161. Epub 2018 Jan 23.

PMID:
29359607
3.

Inhaled Corticosteroids in Asthma: Promoting or Protecting Against Atherosclerosis?

Podgórski M, Kupczyk M, Grzelak P, Bocheńska-Marciniak M, Polguj M, Kuna P, Stefańczyk L.

Med Sci Monit. 2017 Nov 9;23:5337-5344.

4.

How should treatment approaches differ depending on the severity of asthma?

Kupczyk M, Kuna P.

Expert Rev Respir Med. 2017 Dec;11(12):991-1001. doi: 10.1080/17476348.2017.1388742. Epub 2017 Oct 16. Review.

PMID:
28976216
5.

Authors' Reply to Yilmaz and Türk: "Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives".

Kupczyk M, Kuna P.

Drugs. 2017 Nov;77(17):1927-1928. doi: 10.1007/s40265-017-0822-1. No abstract available.

PMID:
28975592
6.

Functional phenotypes determined by fluctuation-based clustering of lung function measurements in healthy and asthmatic cohort participants.

Delgado-Eckert E, Fuchs O, Kumar N, Pekkanen J, Dalphin JC, Riedler J, Lauener R, Kabesch M, Kupczyk M, Dahlen SE, Mutius EV, Frey U; PASTURE and BIOAIR Study groups.

Thorax. 2018 Feb;73(2):107-115. doi: 10.1136/thoraxjnl-2016-209919. Epub 2017 Sep 2.

PMID:
28866644
7.

Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives.

Kupczyk M, Kuna P.

Drugs. 2017 Aug;77(12):1281-1294. doi: 10.1007/s40265-017-0777-2. Review.

8.

Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project).

Bousquet J, Agache I, Aliberti MR, Angles R, Annesi-Maesano I, Anto JM, Arnavielhe S, Asayag E, Bacci E, Bedbrook A, Bachert C, Baroni I, Barreto BA, Bedolla-Barajas M, Bergmann KC, Bertorello L, Bewick M, Bieber T, Birov S, Bindslev-Jensen C, Blua A, Bochenska Marciniak M, Bogus-Buczynska I, Bosnic-Anticevich S, Bosse I, Bourret R, Bucca C, Buonaiuto R, Burguete Cabanas MT, Caillaud D, Caimmi DP, Caiazza D, Camargos P, Canfora G, Cardona V, Carriazo AM, Cartier C, Castellano G, Chavannes NH, Cecci L, Ciaravolo MM, Cingi C, Ciceran A, Colas L, Colgan E, Coll J, Conforti D, Correia de Sousa J, Cortés-Grimaldo RM, Corti F, Costa E, Courbis AL, Cousein E, Cruz AA, Custovic A, Cvetkovski B, Dario C, da Silva J, Dauvilliers Y, De Blay F, Dedeu T, De Feo G, De Martino B, Demoly P, De Vries G, Di Capua Ercolano S, Di Carluccio N, Doulapsi M, Dray G, Dubakiene R, Eller E, Emuzyte R, Espinoza-Contreras JG, Estrada-Cardona A, Farrell J, Farsi A, Ferrero J, Fokkens WJ, Fonseca J, Fontaine JF, Forti S, Gálvez-Romero JL, García-Cobas CI, Garcia Cruz MH, Gemicioğlu B, Gerth van Wijk R, Guidacci M, Gómez-Vera J, Guldemond NA, Gutter Z, Haahtela T, Hajjam J, Hellings PW, Hernández-Velázquez L, Illario M, Ivancevich JC, Jares E, Joos G, Just J, Kalayci O, Kalyoncu AF, Karjalainen J, Keil T, Khaltaev N, Klimek L, Kritikos V, Kull I, Kuna P, Kvedariene V, Kolek V, Krzych-Fałta E, Kupczyk M, Lacwik P, La Grutta S, Larenas-Linnemann D, Laune D, Lauri D, Lavrut J, Lessa M, Levato G, Lewis L, Lieten I, Lipiec A, Louis R, Luna-Pech JA, Magnan A, Malva J, Maspero JF, Matta-Campos JJ, Mayora O, Medina-Ávalos MA, Melén E, Menditto E, Millot-Keurinck J, Moda G, Morais-Almeida M, Mösges R, Mota-Pinto A, Mullol J, Muraro A, Murray R, Noguès M, Nalin M, Napoli L, Neffen H, O'Hehir RE, Onorato GL, Palkonen S, Papadopoulos NG, Passalacqua G, Pépin JL, Pereira AM, Persico M, Pfaar O, Pozzi AC, Prokopakis E, Pugin B, Raciborski F, Rimmer J, Rizzo JA, Robalo-Cordeiro C, Rodríguez-González M, Rolla G, Roller-Wirnsberger RE, Romano A, Romano M, Romano MR, Salimäki J, Samolinski B, Serpa FS, Shamai S, Sierra M, Sova M, Sorlini M, Stellato C, Stelmach R, Strandberg T, Stroetmann V, Stukas R, Szylling A, Tan R, Tibaldi V, Todo-Bom A, Toppila-Salmi S, Tomazic P, Trama U, Triggiani M, Valero A, Valovirta E, Valiulis A, van Eerd M, Vasankari T, Vatrella A, Ventura MT, Verissimo MT, Viart F, Williams S, Wagenmann M, Wanscher C, Westman M, Wickman M, Young I, Yorgancioglu A, Zernotti E, Zuberbier T, Zurkuhlen A, De Oliviera B, Senn A.

Allergy. 2018 Jan;73(1):77-92. doi: 10.1111/all.13218. Epub 2017 Aug 24.

PMID:
28600902
9.

Safety and efficacy of venom immunotherapy: a real life study.

Kołaczek A, Skorupa D, Antczak-Marczak M, Kuna P, Kupczyk M.

Postepy Dermatol Alergol. 2017 Apr;34(2):159-167. doi: 10.5114/ada.2017.67082. Epub 2017 Apr 13.

10.

Asthma research in Europe: a transformative agenda for innovation and competitiveness.

Papadopoulos NG, Androutsopoulou A, Akdis C, Dahlén SE, Djukanovic R, Edwards J, Garcia-Marcos L, Johnston SL, Kupczyk M, Martin TR, Myles D, Palkonen S, Powell P, Riley J, Walker S.

Eur Respir J. 2017 May 1;49(5). pii: 1602294. doi: 10.1183/13993003.02294-2016. Print 2017 May. No abstract available.

PMID:
28461296
11.

Building the investment case for asthma R&D: the European Asthma Research and Innovation Partnership argument.

Walker SM, Akdis C, Dahlen SE, Djukanovic R, Edwards J, Garcia-Marcos L, Johnston S, Kupczyk M, Martin T, Myles D, Palkonen S, Papadopoulos N, Powell P, Riley J.

Clin Exp Allergy. 2016 Sep;46(9):1136-8. doi: 10.1111/cea.12779. No abstract available.

PMID:
27574040
12.

Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.

James AJ, Reinius LE, Verhoek M, Gomes A, Kupczyk M, Hammar U, Ono J, Ohta S, Izuhara K, Bel E, Kere J, Söderhäll C, Dahlén B, Boot RG, Dahlén SE; BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium.

Am J Respir Crit Care Med. 2016 Jan 15;193(2):131-42. doi: 10.1164/rccm.201504-0760OC.

PMID:
26372680
13.

National and regional asthma programmes in Europe.

Selroos O, Kupczyk M, Kuna P, Łacwik P, Bousquet J, Brennan D, Palkonen S, Contreras J, FitzGerald M, Hedlin G, Johnston SL, Louis R, Metcalf L, Walker S, Moreno-Galdó A, Papadopoulos NG, Rosado-Pinto J, Powell P, Haahtela T.

Eur Respir Rev. 2015 Sep;24(137):474-83. doi: 10.1183/16000617.00008114. Review.

14.

The prevalence of asthma work relatedness: Preliminary data.

Dudek W, Kupryś-Lipińska I, Wittczak T, Świerczyńska-Machura D, Kupczyk M, Walusiak-Skorupa J, Kuna P, Pałczyński C.

Int J Occup Med Environ Health. 2015;28(6):1025-9. doi: 10.13075/ijomeh.1896.00513.

15.

The statement of the Polish Society of Allergology experts on the treatment of difficult-to-treat asthma.

Bodzenta-Łukaszyk A, Fal AM, Jassem E, Kowalski ML, Kuna P, Kupczyk M.

Pneumonol Alergol Pol. 2015;83(4):324-34. doi: 10.5603/PiAP.2015.0052.

16.

Long term effect and allergic sensitization in newly employed workers in laboratory animal facilities.

Palmberg L, Sundblad BM, Lindberg A, Kupczyk M, Sahlander K, Larsson K.

Respir Med. 2015 Sep;109(9):1164-73. doi: 10.1016/j.rmed.2015.06.007. Epub 2015 Jun 15.

17.

Tiotropium and its efficacy in the treatment of COPD.

Kupczyk M, Szepiel P, Kuna P.

Pneumonol Alergol Pol. 2015;83(3):229-37. doi: 10.5603/PiAP.2015.0037. Review.

18.

The relative values of CD8+CD25+Foxp3brigh Treg cells correlate with selected lung function parameters in asthma.

Eusebio M, Kuna P, Kraszula L, Kupczyk M, Pietruczuk M.

Int J Immunopathol Pharmacol. 2015 Jun;28(2):218-26. doi: 10.1177/0394632015584508. Epub 2015 Apr 28.

PMID:
25921629
19.

Thixotropy of nasal medications—its role in clinical practice.

Koźmiński M, Kupczyk M.

Pneumonol Alergol Pol. 2015;83(2):157-63. doi: 10.5603/PiAP.2015.0025.

20.

POLASTMA--the Polish National Programme of Early Diagnosis and Therapy of Asthma.

Kuna P, Kupczyk M, Kupryś-Lipińska I.

Pneumonol Alergol Pol. 2014;82(6):597-607. doi: 10.5603/PiAP.2014.0079.

21.

Allergy-related changes in levels of CD8+CD25+FoxP3(bright) Treg cells and FoxP3 mRNA expression in peripheral blood: the role of IL-10 or TGF-beta.

Eusebio M, Kuna P, Kraszula L, Kupczyk M, Pietruczuk M.

J Biol Regul Homeost Agents. 2014 Jul-Sep;28(3):461-70.

PMID:
25316133
22.

Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma.

Kupczyk M, Dahlén B, Sterk PJ, Nizankowska-Mogilnicka E, Papi A, Bel EH, Chanez P, Howarth PH, Holgate ST, Brusselle G, Siafakas NM, Gjomarkaj M, Dahlén SE; BIOAIR investigators.

Allergy. 2014 Sep;69(9):1198-204. doi: 10.1111/all.12445. Epub 2014 Jul 8.

PMID:
25039610
23.

Omalizumab in an allergology clinic: real life experience and future developments.

Kupczyk M, Kuna P.

Postepy Dermatol Alergol. 2014 Feb;31(1):32-5. doi: 10.5114/pdia.2014.40657. Epub 2014 Feb 25. Review.

24.

[MicroRNAs--new biomarkers of respiratory tract diseases].

Kupczyk M, Kuna P.

Pneumonol Alergol Pol. 2014;82(2):183-90. doi: 10.5603/PiAP.2014.0024. Review. Polish.

25.

Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma.

Daham K, James A, Balgoma D, Kupczyk M, Billing B, Lindeberg A, Henriksson E, FitzGerald GA, Wheelock CE, Dahlén SE, Dahlén B.

J Allergy Clin Immunol. 2014 Aug;134(2):306-13. doi: 10.1016/j.jaci.2013.12.002. Epub 2014 Jan 22.

PMID:
24461582
26.

Frequent exacerbators--a distinct phenotype of severe asthma.

Kupczyk M, ten Brinke A, Sterk PJ, Bel EH, Papi A, Chanez P, Nizankowska-Mogilnicka E, Gjomarkaj M, Gaga M, Brusselle G, Dahlén B, Dahlén SE; BIOAIR investigators.

Clin Exp Allergy. 2014 Feb;44(2):212-21. doi: 10.1111/cea.12179.

PMID:
24447083
27.
28.

The effects of interleukin-10 or TGF-beta on anti-CD3/CD28 induced activation of CD8+CD28- and CD8+CD28+ T cells in allergic asthma.

Eusebio M, Kraszula L, Kupczyk M, Kuna P, Pietruczuk M.

J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):681-92.

PMID:
24152837
29.

Phenotypic predictors of response to oral glucocorticosteroids in severe asthma.

Kupczyk M, Haque S, Middelveld RJ, Dahlén B, Dahlén SE; BIOAIR Investigators.

Respir Med. 2013 Oct;107(10):1521-30. doi: 10.1016/j.rmed.2013.07.014. Epub 2013 Aug 27.

30.

The number needed to treat provides additional insight on the performance of detection points of asthma exacerbations in self-management plans: authors' response on behalf of the BIOAIR consortium.

Kupczyk M, Dahlen SE.

Thorax. 2013 Nov;68(11):1070. doi: 10.1136/thoraxjnl-2013-203952. Epub 2013 Jun 22. No abstract available.

PMID:
23794190
31.

Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis.

Tworek D, Bochenska-Marciniak M, Kuprys-Lipinska I, Kupczyk M, Kuna P.

Am J Rhinol Allergy. 2013 Jul-Aug;27(4):304-8. doi: 10.2500/ajra.2013.27.3935. Epub 2013 Apr 29.

32.

Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study.

Kupczyk M, Haque S, Sterk PJ, Niżankowska-Mogilnicka E, Papi A, Bel EH, Chanez P, Dahlén B, Gaga M, Gjomarkaj M, Howarth PH, Johnston SL, Joos GF, Kanniess F, Tzortzaki E, James A, Middelveld RJ, Dahlén SE; BIOAIR investigators.

Thorax. 2013 Jul;68(7):611-8. doi: 10.1136/thoraxjnl-2012-201815. Epub 2013 Apr 6.

PMID:
23564399
33.

DNA methylation in the Neuropeptide S Receptor 1 (NPSR1) promoter in relation to asthma and environmental factors.

Reinius LE, Gref A, Sääf A, Acevedo N, Joerink M, Kupczyk M, D'Amato M, Bergström A, Melén E, Scheynius A, Dahlén SE; BIOAIR Study Group, Pershagen G, Söderhäll C, Kere J.

PLoS One. 2013;8(1):e53877. doi: 10.1371/journal.pone.0053877. Epub 2013 Jan 23.

34.
35.

Transcriptome analysis reveals upregulation of bitter taste receptors in severe asthmatics.

Orsmark-Pietras C, James A, Konradsen JR, Nordlund B, Söderhäll C, Pulkkinen V, Pedroletti C, Daham K, Kupczyk M, Dahlén B, Kere J, Dahlén SE, Hedlin G, Melén E.

Eur Respir J. 2013 Jul;42(1):65-78. doi: 10.1183/09031936.00077712. Epub 2012 Dec 6.

36.

[The use of multi-color flow cytometry for identification of functional markers of nTregs in patients with severe asthma].

Kraszula L, Eusebio M, Kupczyk M, Kuna P, Pietruczuk M.

Pneumonol Alergol Pol. 2012;80(5):389-401. Polish.

37.

Low frequency of CD8+CD25+FOXP3(BRIGHT) T cells and FOXP3 mRNA expression in the peripheral blood of allergic asthma patients.

Eusebio M, Kraszula L, Kupczyk M, Kuna P, Pietruczuk M.

J Biol Regul Homeost Agents. 2012 Apr-Jun;26(2):211-20.

PMID:
22824748
38.

U.S. and European severe asthma cohorts: what can they teach us about severe asthma?

Kupczyk M, Wenzel S.

J Intern Med. 2012 Aug;272(2):121-32. doi: 10.1111/j.1365-2796.2012.02558.x. Review.

39.

Which anti-inflammatory drug should we use in asthma?

Kupczyk M, Dahlén B, Dahlén SE.

Pol Arch Med Wewn. 2011 Dec;121(12):455-9. Review.

40.

Will recording of lung function fluctuation open the door to internet-guided treatment of asthma?

Kupczyk M, Dahlén SE.

Thorax. 2011 Dec;66(12):1019-20. doi: 10.1136/thoraxjnl-2011-200847. Epub 2011 Aug 19. No abstract available.

PMID:
21856700
41.

Solution-engineered palladium nanoparticles: model for health effect studies of automotive particulate pollution.

Wilkinson KE, Palmberg L, Witasp E, Kupczyk M, Feliu N, Gerde P, Seisenbaeva GA, Fadeel B, Dahlén SE, Kessler VG.

ACS Nano. 2011 Jul 26;5(7):5312-24. doi: 10.1021/nn1032664. Epub 2011 Jun 13.

PMID:
21650217
42.

Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.

Kuna P, Kaczmarek J, Kupczyk M.

J Allergy Clin Immunol. 2011 Feb;127(2):502-508.e1-6. doi: 10.1016/j.jaci.2010.11.036.

PMID:
21281874
43.

Effects of celecoxib on major prostaglandins in asthma.

Daham K, Song WL, Lawson JA, Kupczyk M, Gülich A, Dahlén SE, FitzGerald GA, Dahlén B.

Clin Exp Allergy. 2011 Jan;41(1):36-45. doi: 10.1111/j.1365-2222.2010.03617.x. Epub 2010 Sep 28.

PMID:
20880055
44.

Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge.

Kupczyk M, Kurmanowska Z, Kupryś-Lipińska I, Bocheńska-Marciniak M, Kuna P.

Respir Med. 2010 Oct;104(10):1404-9. doi: 10.1016/j.rmed.2010.04.017. Epub 2010 May 10.

45.

[Acoustic rhinometry in the evaluation of intranasal aspirin challenge].

Kupczyk M, Kupryś-Lipińska I, Bocheńska-Marciniak M, Kuna P.

Pneumonol Alergol Pol. 2010;78(2):103-11. Polish.

46.

Reduction of asthma burden is possible through National Asthma Plans.

Kupczyk M, Haahtela T, Cruz AA, Kuna P.

Allergy. 2010 Apr;65(4):415-9. doi: 10.1111/j.1398-9995.2009.02265.x. Epub 2010 Jan 22. Review.

PMID:
20102359
47.

Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model.

Kupczyk M, Antczak A, Kuprys-Lipinska I, Kuna P.

Allergy. 2009 Dec;64(12):1746-52. doi: 10.1111/j.1398-9995.2009.02047.x. Epub 2009 Apr 6.

PMID:
19385948
48.

Intravenous iron sucrose changes the intraperitoneal homeostasis.

Breborowicz A, Połubinska A, Kupczyk M, Wanic-Kossowka M, Oreopoulos DG.

Blood Purif. 2009;28(1):53-8. doi: 10.1159/000210038. Epub 2009 Mar 27.

PMID:
19325240
49.
50.

Life threatening pneumonia in a lupus patient: a case report.

Kupczyk M, Antczak A, Kuna P, Górski P.

Cases J. 2008 Jul 31;1(1):70. doi: 10.1186/1757-1626-1-70.

Supplemental Content

Loading ...
Support Center